Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 202079

Expand all

CANDESARTAN CILEXETIL (CANDESARTAN CILEXETIL)
4MG
Marketing Status: Discontinued

Active Ingredient: CANDESARTAN CILEXETIL
Proprietary Name: CANDESARTAN CILEXETIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 4MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202079
Product Number: 001
Approval Date: Jan 10, 2014
Applicant Holder Full Name: APOTEX INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

CANDESARTAN CILEXETIL (CANDESARTAN CILEXETIL)
8MG
Marketing Status: Discontinued

Active Ingredient: CANDESARTAN CILEXETIL
Proprietary Name: CANDESARTAN CILEXETIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 8MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202079
Product Number: 002
Approval Date: Jan 10, 2014
Applicant Holder Full Name: APOTEX INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

CANDESARTAN CILEXETIL (CANDESARTAN CILEXETIL)
16MG
Marketing Status: Discontinued

Active Ingredient: CANDESARTAN CILEXETIL
Proprietary Name: CANDESARTAN CILEXETIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 16MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202079
Product Number: 003
Approval Date: Jan 10, 2014
Applicant Holder Full Name: APOTEX INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

CANDESARTAN CILEXETIL (CANDESARTAN CILEXETIL)
32MG
Marketing Status: Discontinued

Active Ingredient: CANDESARTAN CILEXETIL
Proprietary Name: CANDESARTAN CILEXETIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 32MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202079
Product Number: 004
Approval Date: Jan 10, 2014
Applicant Holder Full Name: APOTEX INC
Marketing Status:  Discontinued
Patent and Exclusivity Information